Itzhak Kelson News Today

- Presented preclinical data demonstrating abscopal immune effect in pancreatic murine tumor models at ESTRO 2024 Congress in Glasgow -

- Interim data read-out of the first five treated patients demonstrated successful delivery in all five cases, as well as no product-related Serious Adverse Events - - First five patients received...

- Interim data read-out of the first five treated patients demonstrated successful delivery in all five cases, as well as no product-related Serious Adverse Events -

JERUSALEM, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Alpha Tau Medical Ltd. ("Alpha Tau", or the "Company") (NASDAQ:DRTS, DRTSW)), the developer of the innovative alpha-radiation cancer therapy Alpha DaRT™,

September 27, 2023 Dear Alpha Tau Medical Ltd. Shareholders: We cordially invite you to attend the annual general meeting of shareholders of Alpha Tau Medical...

– Treated the first patient with advanced inoperable pancreatic cancer in a safety and feasibility trial in Canada in April –– 89% CR, two-year lo...

– Treated the first patient with advanced inoperable pancreatic cancer in a safety and feasibility trial in Canada in April – – 89% CR, two-year local recurrence-free survival of 77%, and no...

- 81 lesions treated across four feasibility trials of head and neck or skin cancers demonstrated 89% complete response rate.

-First patient treated in the feasibility and safety study of intratumoral diffusing alpha-emitters radiation therapy for the treatment of new and recurrent squamous cell carcinoma of the... | May 17, 2023

Data shows rise of over 120% in startups set up yearly by academic institutions, from 34 in 2016 to 75 in 2020, accounting for 13% of total new startups set up in Israel